HYBRID EVENT: You can participate in person at Baltimore, Maryland, USA or Virtually from your home or work.

5th Edition of Global Conference on

Addiction Medicine, Behavioral Health and Psychiatry

October 21-23, 2024 | Baltimore, Maryland, USA

GAB 2024

Brandon Laidlaw

Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2024 - Brandon Laidlaw
Medea Inc, United States
Title : Fighting the fentanyl crisis: Making opioid overdose reversal agents more accessible to communities in need

Abstract:

Medea, Inc. is a North American medical and pharmaceutical procurement company specializing in sourcing and distributing a wide range of high-quality FDA-approved medical products for federal and state government entities.

Brandon Laidlaw, CEO and chairman of Medea, will discuss how communities can significantly reduce opioid overdoses and save lives by making opioid overdose reversal agents more accessible. Attendees will learn how to fight the growing fentanyl crisis in their communities and save lives by gaining access to opioid overdose reversal agents through partnerships with trusted procurement companies like Medea. Target audiences will include local state and city government officials responsible for community health.

Brandon will highlight two specific case studies.

The first is a partnership with Orange County, Calif.

In June 2023, Medea partnered with Orange County to help save the lives of OC residents by preventing fentanyl and other opioid-related deaths. The company did so by serving as the authorized distributor of 7,500 units of 8 mg (Kloxxado) naloxone nasal spray, a life-saving medicine that can revive someone experiencing an overdose, to Orange County - the first California County to do so.

The second case study will focus on Medea’s partnership with CalOptima Health.

Medea was the company behind CalOptima Health’s Dec. 2023 community event that distributed naloxone - for free - to those covered by CalOptima Health. Brandon will discuss these important initiatives and results in his presentation. 

By partnering with Orange County, Calif. and expanding our government contracts nationwide, Medea hopes to save hundreds of thousands of lives by preventing opioid overdose-related deaths.

Audience Take Away Notes:

Our session will address how communities can significantly reduce opioid overdoses and save lives by making opioid overdose reversal agents more accessible. Audience members will learn the importance of working with trusted procurement companies like Medea and how to do so. Audience members also will learn how to generate partnerships with local authorities to fight the fentanyl crisis. Finally, audience members will learn more about the growing fentanyl crisis and about opioid overdose reversal agents.

Biography:

Brandon Laidlaw is CEO and chairman of Medea, Inc., a North American medical and pharmaceutical procurement company specializing in sourcing and distributing a wide range of high-quality FDA-approved medical products for federal and state government entities. As a seasoned executive who has successfully formed strategic alliances and built brands with top-tier retailers in new and emerging markets, Laidlaw has helped Medea secure more than $1 billion in partnerships with the Department of Defense, Department of Homeland Security, and state governments since its founding in 2014.

Watsapp